Specialty focus Primus operates as a specialty pharmaceutical company with a focus on dermatology, rheumatology, internal medicine, vascular health, obstetrics/gynecology, pain management, orthopedics and podiatry. This suggests opportunities to cross-sell to clinics and specialists within these therapeutic areas and to align product messaging with provider needs around safety and efficacy.

Delivery innovations The company emphasizes proprietary topical delivery systems, a non-active-ingredient medical device, and plant-based medical foods. This opens doors for partnerships with dermatology clinics, wound care centers, and integrated wellness programs that value safer, efficacious, and patient-friendly alternatives to traditional therapies.

Mid-market focus With a headcount in the 51-200 range and annual revenue in the $50M-$100M band, Primus sits in the mid-market segment. There is potential for scalable distribution partnerships, contract manufacturing discussions, and regional reps to expand market reach without the complexity of large enterprise deals.

Technology-enabled sales Existing tech stack includes Medrio, Microsoft 365, JotForm and Google Maps, indicating readiness for streamlined customer onboarding, regulatory documentation, and field operations. Leverage these tools to implement targeted outreach, digital demonstrations, and efficient contract processing with healthcare providers.

Growth signals The company’s described safety-first, patient-centric approach and diverse therapeutic portfolio align with growing demand for safer, plant-based and device-assisted therapies. This positions Primus to pursue partnerships with specialty clinics, patient advocacy groups, and payers seeking value-based care across dermatology and musculoskeletal indications.